Efficacy of sitafloxacin as third-line eradication treatment of Helicobacter pylori
Phase 2
- Conditions
- H. pylori infection
- Registration Number
- JPRN-UMIN000004778
- Lead Sponsor
- ational Organization Tokyo medical center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient with severe heart failure, renal failure or infection. 2. Patients with allergy for rabeprazole, amoxicillin or sitafloxacin. 3. Pregnant patient.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication rate
- Secondary Outcome Measures
Name Time Method